Incidental Detection of Meningioma on 18 F-Flutemetamol PET

Young-Sil An1, So Young Moon2, Tae Hoon Roh3

  • 1Department of Nuclear Medicine and Molecular Imaging.

PubMed

Insights

18F-flutemetamol PET/CT can reveal incidental meningiomas in dementia evaluations. Delayed imaging shows intense uptake, aiding diagnosis of these benign brain tumors.

Area of Science:

  • Neurology
  • Nuclear Medicine
  • Oncology

Background:

  • Meningiomas are typically benign tumors often discovered incidentally.
  • Dementia evaluations frequently involve advanced imaging techniques.

Purpose of the Study:

  • To demonstrate the utility of 18F-flutemetamol (FMM) PET/CT in identifying incidental meningiomas.
  • To provide a reference for interpreting incidental lesions on FMM PET/CT scans.

Main Methods:

  • Case study of an 80-year-old woman evaluated for memory decline.
  • Utilized 18F-flutemetamol (FMM) PET/CT with early and delayed phase imaging.
  • Confirmed findings with Magnetic Resonance Imaging (MRI) and surgical pathology.

Main Results:

  • An incidental frontal mass was detected during a dementia assessment FMM PET/CT scan.
  • The lesion showed low initial uptake but intense uptake in delayed-phase imaging.
  • MRI and pathology confirmed the incidental finding as a meningioma.

Conclusions:

  • 18F-FMM PET/CT can be valuable for detecting incidental meningiomas.
  • Delayed-phase imaging is crucial for identifying characteristic intense uptake in meningiomas.
  • This case aids physicians in interpreting incidental masses found during FMM PET/CT scans.